Drupal.behaviors.print = function(context) {window.print();window.close();}>
VelaDx Licenses Swift Bio's Primer Technology for PCR-based Dx
December 03, 2012
VelaDx Licenses Swift Bio's Primer Technology for PCR-based Dx
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Swift Biosciences Licenses Primer Tech to Vela Diagnostics
December 6, 2012 / PCR Insider
Trovagene, PerkinElmer Ink Assay Development Deal Targeting Liver Cancer
April 26, 2013 / GenomeWeb Daily News
Seegene, Selventa Partner on MDx Development for 'Underserved Markets'
April 23, 2013 / GenomeWeb Daily News
AmoyDx Cancer Detection Kit Approved by Chinese Regulators
March 20, 2013 / GenomeWeb Daily News
Cepheid, OHSU Co-developing Cancer MDx Tests for GeneXpert
February 19, 2013 / GenomeWeb Daily News